ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Open-Label, Extension Trial to Demonstrate the Effectiveness and Safety of L-CsA Plus Standard of Care in the Treatment of BOS in Patients Post Single or Double Lung Transplant
Case Medical Research
◽
10.31525/ct1-nct04039347
◽
2019
◽
Author(s):
Keyword(s):
Lung Transplant
◽
Standard Of Care
◽
Open Label
◽
Open Label Extension
◽
Extension Trial
Download Full-text
Related Documents
Cited By
References
Continuous Weekly Adalimumab is the Optimal Long-Term Strategy for Patients with Moderate-to-Severe Hidradenitis Suppurativa: Results from the PIONEER Open Label Extension Trial
SKIN The Journal of Cutaneous Medicine
◽
10.25251/skin.1.supp.128
◽
2017
◽
Vol 1
◽
pp. s129
Author(s):
Alexa B Kimball
◽
Martin M Okun
◽
Gerit Mulder
Keyword(s):
Hidradenitis Suppurativa
◽
Open Label
◽
Open Label Extension
◽
Extension Trial
Abstract Not Available Disclosures: Study supported by AbbVie.
Download Full-text
Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension Trial
Case Medical Research
◽
10.31525/ct1-nct03836716
◽
2000
◽
Author(s):
Keyword(s):
Open Label
◽
Amyotropic Lateral Sclerosis
◽
Open Label Extension
◽
Extension Trial
◽
Lateral Sclerosis
Download Full-text
An Open Label Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Disorder
Case Medical Research
◽
10.31525/ct1-nct04186403
◽
2019
◽
Author(s):
Keyword(s):
Borderline Personality Disorder
◽
Personality Disorder
◽
Borderline Personality
◽
Open Label
◽
Open Label Extension
◽
Extension Trial
Download Full-text
Faculty Opinions recommendation of Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters: An open-label extension trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.736282945.793563275
◽
2019
◽
Author(s):
John Paul Leach
Keyword(s):
Nasal Spray
◽
Outpatient Treatment
◽
Open Label
◽
Safety And Efficacy
◽
Open Label Extension
◽
Extension Trial
Download Full-text
Disease-modifying effects of edasalonexent, an NF-κB inhibitor, in young boys with Duchenne muscular dystrophy: Results of the MoveDMD phase 2 and open label extension trial
Neuromuscular Disorders
◽
10.1016/j.nmd.2021.02.001
◽
2021
◽
Author(s):
Richard S. Finkel
◽
Erika Finanger
◽
Krista Vandenborne
◽
H. Lee Sweeney
◽
Gihan Tennekoon
◽
...
Keyword(s):
Duchenne Muscular Dystrophy
◽
Muscular Dystrophy
◽
Phase 2
◽
Open Label
◽
Open Label Extension
◽
Disease Modifying
◽
Extension Trial
Download Full-text
Long‐term efficacy and safety of risankizumab for the treatment of moderate‐to‐severe plaque psoriasis: interim analysis of the LIMMitless open‐label extension trial beyond 3 years of follow‐up
British Journal of Dermatology
◽
10.1111/bjd.20595
◽
2021
◽
Author(s):
K.A. Papp
◽
M.G. Lebwohl
◽
L. Puig
◽
M. Ohtsuki
◽
S. Beissert
◽
...
Keyword(s):
Plaque Psoriasis
◽
Interim Analysis
◽
Efficacy And Safety
◽
Open Label
◽
Severe Plaque Psoriasis
◽
Term Efficacy
◽
Open Label Extension
◽
Extension Trial
Download Full-text
Long‐term safety and efficacy of add‐on cannabidiol in patients with Lennox–Gastaut syndrome: Results of a long‐term open‐label extension trial
Epilepsia
◽
10.1111/epi.17000
◽
2021
◽
Author(s):
Anup D. Patel
◽
Maria Mazurkiewicz‐Bełdzińska
◽
Richard F. Chin
◽
Antonio Gil‐Nagel
◽
Boudewijn Gunning
◽
...
Keyword(s):
Open Label
◽
Safety And Efficacy
◽
Open Label Extension
◽
Extension Trial
Download Full-text
Long-Term Safety and Efficacy of Risankizumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: Results from a Phase 2 Open-Label Extension Trial
Dermatology and Therapy
◽
10.1007/s13555-021-00490-3
◽
2021
◽
Author(s):
Kim A. Papp
◽
Saskia de Vente
◽
Jiewei Zeng
◽
Mary Flack
◽
Byron Padilla
◽
...
Keyword(s):
Plaque Psoriasis
◽
Phase 2
◽
Chronic Plaque Psoriasis
◽
Open Label
◽
Safety And Efficacy
◽
Open Label Extension
◽
Extension Trial
Download Full-text
An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia
Clinical Therapeutics
◽
10.1016/s0149-2918(03)80168-6
◽
2003
◽
Vol 25
(6)
◽
pp. 1765-1782
◽
Cited By ~ 47
Author(s):
Timo Erkinjuntti
◽
Alexander Kurz
◽
Gary W Small
◽
Roger Bullock
◽
Sean Lilienfeld
◽
...
Keyword(s):
Vascular Dementia
◽
Mixed Dementia
◽
Open Label
◽
Open Label Extension
◽
Extension Trial
Download Full-text
Faculty Opinions recommendation of Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.727479881.793555215
◽
2019
◽
Author(s):
Roser Torra
Keyword(s):
Kidney Disease
◽
Autosomal Dominant
◽
Efficacy And Safety
◽
Polycystic Kidney
◽
Open Label
◽
Delayed Treatment
◽
Open Label Extension
◽
Autosomal Dominant Polycystic Kidney
◽
Extension Trial
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close